CoChat

Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis

Delobel, Patrice, Flament, Stéphane, Hamdane, Malika, Mailliot, Christel, Sambo, Anne‐Véronique, Bégard, Séverine, Sergeant, Nicolas, Delacourte, André, Vilain, Jean‐Pierre, Buée, Luc · 2002 · Journal of Neurochemistry
Cited by 72

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

In Alzheimer's disease, neurofibrillary degeneration results from the aggregation of abnormally phosphorylated Tau proteins into filaments and it may be related to the reactivation of mitotic mechanisms. In order to investigate the link between Tau phosphorylation and mitosis, Xenopus laevis oocytes in which most of the M‐phase regulators have been discovered were used as a cell model. The human Tau isoform htau412 (2+3–10+) was microinjected into prophase I oocytes that were then stimulated by progesterone that activate cyclin‐dependent kinase pathways. Hyperphosphorylation of the Tau isoform, which is characterized by a decrease of its electrophoretic mobility and its labelling by a number of phosphorylation‐dependent antibodies, was observed at the time of germinal vesicle breakdown. Surprisingly, Tau immunoreactivity, considered as typical of Alzheimer's pathology (AT100 and phospho‐Ser422), was observed in meiosis II. Because meiosis II is considered as a mitosis‐like phase, we investigated if our observation was also relevant to a neurone‐like model. Abnormal Tau phosphorylation was detected in mitotic human neuroblastoma SY5Y cells overexpressing Tau. Regarding AT100‐immunoreactivity and phospho‐Ser422, we suggest that phosphatase 2A inhibition and a phosphorylation combination of mitotic kinases may lead to this Alzheimer‐type phosphorylation. Our results not only demonstrate the involvement of mitotic kinases in Alzheimer‐type Tau phosphorylation but also indicate that Xenopus oocyte could be a useful model to identify the kinases involved in this process.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2002.01143.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 72

Metadata

Authors
Delobel, P., Flament, S., Hamdane, M., Mailliot, C., Sambo, A., Bégard, S., Sergeant, N., Delacourte, A., Vilain, J., & Buée, L.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2002-10
Volume
83
Issue
2
Pages
412-420
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1539836937
Cited by
72
References
3
FWCI
2.39
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis. https://app.cochat.ai/papers/10.1046/j.1471-4159.2002.01143.x
The paper
Delobel, P., Flament, S., Hamdane, M., Mailliot, C., Sambo, A., Bégard, S., Sergeant, N., Delacourte, A., Vilain, J., & Buée, L. (2002). Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.2002.01143.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.